# Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults

> clinical trial · VERIFIED · 2026-08-11

Status: NOT_YET_RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: HIV

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07757802

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
